Arixtra
NDC 67457-594, fondaparinux sodium, injection, solution, from Mylan Institutional LLC.
- Product NDC
- 67457-594
- Status
- Listed
- Labeler
- Mylan Institutional LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA021345
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67457-594 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FONDAPARINUX SODIUM7.5 mg/.6mL
Pharmacologic classes
Factor Xa Inhibitor [EPC]; Factor Xa Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67457-594-06 | 67457059406 | 10 SYRINGE, GLASS in 1 CARTON (67457-594-06) / .6 mL in 1 SYRINGE, GLASS (67457-594-00) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/d3b30c68-cf45-4b46-8ba6-72090f7ba01aMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=67457-594
Use it
Look up 67457-594 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67457-594 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67457-594. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.